...

Mo1527 HIGH SERUM LEVELS OF INTERLEUKIN-10, MACROPHAGE COLONYSTIMULATING FACTOR AND SOLUBLE CD40L INDEPENDENTLY PREDICT 90-DAY MORTALITY IN SEVERE ...

Mo1526 ANAKINRA + ZINC TREATMENT IN PATIENTS WITH SEVERE ALCOHOLASSOCIATED HEPATITIS REDUCED SERUM CCL11 AND G-CSF IN A 28 DAY PERIOD: A MULTICENTER SERUM ...

Sa1634 THE DIAGNOSTIC MODELS BASED ON MACHINE LEARNING FOR IDENTIFYING ADVANCED FIBROSIS AND CIRRHOSIS IN CHRONIC HEPATITIS B PATIENTS WITH CONCUEERNT ...

Tu1420 THE ASSOCIATION OF HEPATITIS C VIRUS ON THE RISK OF PANCREATIC CANCER

Sa1630 CORRECTION OF VITAMIN D DEFICIENCY PROMOTED AN ACCELERATED DECLINE OF QUANTITATIVE HEPATITIS B SURFACE ANTIGEN LEVELS IN PATIENTS WITH CHRONIC ...

Mo1567 TREATMENT OUTCOMES OF IMMUNE CHECKPOINT INHIBITOR (ICI) HEPATITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS

104 THE CONTINUED ALARMING RISE IN RATES OF ALCOHOL ASSOCIATED HEPATITIS AMONG U.S. VETERANS PERSISTS BEYOND THE COVID-19 PANDEMIC

Sa1616 MORTALITY RATES AMONG PATIENTS SUCCESSFULLY TREATED FOR HEPATITIS C: A REAL WORLD MULTINATIONAL COHORT STUDY

Sa1637 PREVALENCE OF HEPATITIS B (HBV) VACCINE-INDUCED IMMUNITY ON LONG-TERM FOLLOW-UP AND OF ANAMNESTIC RESPONSE FOLLOWING VACCINE BOOSTER: A SYSTEMATIC ...